DJIA. (Add your “outperform” vote. Guardant Health does not have a long track record of dividend growth. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and Cowen, Leerink Partners and William Blair were co-managers. Guardant Health has only been the subject of 4 research reports in the past 90 days. Guardant is selling 3,750,000 of the shares and SoftBank Investment Advisers is selling the other 7,750,000 shares. Their forecasts range from $100.00 to $150.00. 8 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. View today's stock price, news and analysis for Guardant Health Inc. (GH). Guardant Health is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. Add to Watchlist. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical trial referral, and liquid biopsy testing development and support services to biopharmaceutical companies and medical institutions. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run w... Will the Guardant Health Inc share price run continue? View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. ), Guardant Health has received 157 “underperform” votes. GH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Morgan Stanley, Point72 Asset Management L.P., Railway Pension Investments Ltd, Charles Schwab Investment Management Inc., Granite Investment Partners LLC, ExodusPoint Capital Management LP, and Rhenman & Partners Asset Management AB. One share of GH stock can currently be purchased for approximately $122.26. You may vote once every thirty days. The Company is focused on helping conquer cancer through use of its blood tests, data sets and analytics. According to analysts' consensus price target of $121.86, Guardant Health has a forecasted downside of 0.3% from its current price of $122.26. Based on our forecasts, a long-term increase is expected, the "GH" stock price prognosis for 2025-12-05 is 227.248 USD. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Guardant Health Inc quote is equal to 126.150 USD at 2020-12-09. Only 9.90% of the stock of Guardant Health is held by insiders. The average price target is $113.00, with a high forecast of $130.00 and a low forecast of $100.00. Company insiders that have sold Guardant Health company stock in the last year include Amirali Talasaz, Bluebird (Cayman) Ltd Svf, Derek A Bertocci, Helmy Eltoukhy, Ian T Clark, Michael J Wiley, Samir Kaul, and Stanley J Meresman. Guardant Health's mailing address is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. The company reported ($0.78) EPS for the quarter, missing the consensus estimate of ($0.34) by $0.44. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Get the latest information on Guardant Health stock (NASDAQ: GH), including a real-time stock price quote, news, financials, charts and more. The company can be reached via phone at 855-698-8887. Most Options traders lose 7 out of 10 trades. It also provides LUNAR-1 for minimal residual disease and recurrence detection in cancer survivors. Guardant Health employs 622 workers across the globe. Looking for new stock ideas? MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. S&P 500. Shares of GH can be purchased through any online brokerage account. The company offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes; and GuardantOMNI, a broader gene panel, including genes associated with homologous recombination repair deficiency and biomarkers for immuno-oncology applications. NEW YORK – Guardant Health said today that it has priced an underwritten public offering of 11.5 million shares of its common stock at a $84 per share. Full Company Report for GH. Guardant Health, Inc. Common Stock (GH) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading … Learn everything you need to know about successful options trading with this three-part video course. Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. Please log in to your account or sign up in order to add this asset to your watchlist. While the F1 consensus estimate and revision is a key driver of stock prices, ... Guardant Health Inc. is based in REDWOOD CITY, United States. Want to see which stocks are moving? GH stock was sold by a variety of institutional investors in the last quarter, including First Trust Advisors LP, ARK Investment Management LLC, Summit Partners Public Asset Management LLC, Jennison Associates LLC, Nuveen Asset Management LLC, Nikko Asset Management Americas Inc., JPMorgan Chase & Co., and Thrivent Financial for Lutherans. Guardant Health's stock was trading at $62.95 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. On average, they expect Guardant Health's stock price to reach $121.86 in the next twelve months. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. View insider buying and selling activity for Guardant Health or or view top insider-buying stocks. Get short term trading ideas from the MarketBeat Idea Engine. Guardant Health, Inc. Prices $1 Billion Convertible Senior Notes Offering. Guardant Health does not currently pay a dividend. 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Guardant Health in the last year. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Their average twelve-month price target is $121.86, predicting that the stock has a possible downside of 1.80%. Learn more. Guardant Health, Inc. was incorporated in 2011 and is headquartered in Redwood City, California. Touch device users, explore by touch or with swipe gestures. Soon, it could detect cancer earlier than ever before. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more. View the latest GH stock quote and chart on MSN Money. Get daily stock ideas top-performing Wall Street analysts. Guardant Health Inc's stock had its IPO on October 4, 2018, making it an older stock than only 5.13% of US equities in our set. Guardant Health has a P/B Ratio of 14.38. View insider buying and selling activity for Guardant Health or view top insider-selling stocks. As of 2020 November 29, Sunday current price of GH stock is 118.660$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Guardant Health, Inc. has been showing a declining tendency so we believe that similar market … View our earnings forecast for Guardant Health. FTSE 100. Real time Guardant Health (GH) stock price quote, stock graph, news & analysis. See what's happening in the market right now with MarketBeat's real-time news feed. Earnings for Guardant Health are expected to grow in the coming year, from ($2.05) to ($1.32) per share. Find out who, why, and what you need to know about this company before it's too late. Identify stocks that meet your criteria using seven unique stock screeners. Some companies that are related to Guardant Health include Laboratory Co. of America (LH), Quest Diagnostics (DGX), Invitae (NVTA), Natera (NTRA), Elekta AB (publ) (EKTAY), CareDx (CDNA), Veracyte (VCYT), Burning Rock Biotech (BNR), Personalis (PSNL), Castle Biosciences (CSTL), Fulgent Genetics (FLGT), Genetron (GTH), RadNet (RDNT), Renalytix AI (RNLX) and Centogene (CNTG). Earnings Announcement for Period Ending Q4/2020. Guardant Health has a market capitalization of $12.22 billion and generates $214.38 million in revenue each year. Learn more. Guardant Health has received 55.01% “outperform” votes from our community. View our full suite of financial calendars and market data tables, all for free. Follow My #1 Rule Instead. High institutional ownership can be a signal of strong market trust in this company. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. If you experience any issues with this process, please contact us for further … Before it's here, it's on the Bloomberg Terminal. Based on aggregate information from My MarketBeat watchlists, some companies that other Guardant Health investors own include NVIDIA (NVDA), The Trade Desk (TTD), Square (SQ), Alibaba Group (BABA), PayPal (PYPL), Shopify (SHOP), Okta (OKTA), Alteryx (AYX), Roku (ROKU) and Twilio (TWLO). $124.09. (NASDAQ: GH) Guardant Health's current Earnings Per Share (EPS) is -$1.28. Should You Buy the Peloton (NASDAQ: PTON) Rally? Company profile page for Guardant Health Inc including stock price, company news, press releases, executives, board members, and contact information View Guardant Health's earnings history. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. NASDAQ. Top institutional shareholders include Morgan Stanley (6.31%), BlackRock Inc. (5.01%), Jennison Associates LLC (3.20%), Nuveen Asset Management LLC (2.88%), Massachusetts Financial Services Co. MA (1.08%) and Allianz Asset Management GmbH (0.95%). Since then, GH stock has increased by 94.2% and is now trading at $122.26. The P/E ratio of Guardant Health is -64.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Data is currently not available. Export data to Excel for your own analysis. Guardant Health had a negative net margin of 67.14% and a negative return on equity of 19.22%. Vote “Outperform” if you believe GH will outperform the S&P 500 over the long term. 29,999.26. The company issued 12,500,000 shares at $15.00-$17.00 per share. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. The high price target for GH is $150.00 and the low price target for GH is $100.00. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. This suggests that the stock has a possible downside of 0.3%. On average, analysts forecast that GH's EPS will be … MarketBeat just released five new trading ideas, but Guardant Health wasn't one of them. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. It provides Guardant Health Oncology Platform. The Guardant Health Inc (NSQ:GH) share price has risen by 10.2% over the past month and it’s currently trading at 95.65. Your current $100 investment may be up to $180.14 in 2025. Sign-up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. This investing legend has flipped options trading upside down... making money on 85% of his trades. View which stocks have been most impacted by COVID-19. Guardant Health's management team includes the following people: Don’t Buy Options. The average price target represents a 1.09% upside from the last price of $111.78. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Announces Proposed Convertible Senior Notes Offering, Liquid Biopsy Market Worth $ 5027.46 Million, Globally, by 2027 at 23.12% CAGR: Verified Market Research, Guardant Health Reports Third Quarter 2020 Financial Results, Liquid Biopsy Market | COVID-19 Recovery and Growth Opportunities | Technavio, Why Blade Urban Air Mobility Decided to Go Public Via SPAC, 505 Penobscot Drive The business's revenue was up 22.8% compared to the same quarter last year. This price target is based on 7 analysts offering 12 month price targets for Guardant Health in the last 3 months. Company Summary x. Get Guardant Health Inc (GH:NASDAQ) real-time stock quotes, news and financial information from CNBC. All rights reserved. The latest Guardant Health Inc USD0.00001 share price. Fundamental company data provided by Morningstar and Zacks Investment Research. Guardant Health, Inc. (NASDAQ:GH) issued its quarterly earnings data on Thursday, November, 5th. Guardant Health has received a consensus rating of Buy. Guardant Health has received 192 “outperform” votes. Receive a free world-class investing education from MarketBeat. The company has collaboration agreement with Radius Health, Inc. to develop liquid biopsy companion diagnostic for elacestrant. 8 equities research analysts have issued 1-year price objectives for Guardant Health's stock. View institutional ownership trends for Guardant Health. With a 5-year investment, the revenue is expected to be around +80.14%. Do Not Sell My Information. When autocomplete results are available use up and down arrows to review and enter to select. GH's price/sales ratio is 46.45; that's higher than the P/S ratio of 95.01% of US stocks. In addition, the company is developing LUNAR-2 for early detection of cancer in higher risk individuals. View analyst ratings for Guardant Health or view MarketBeat's top 5 stock picks. Types of investments, trading strategies and more a small group of investors will outperform the S & P over! “ underperform ” if you believe GH will underperform the S & 500. That meet your criteria using seven unique stock screeners making money on 85 % of US stocks using unique... The Pandemic a simple blood draw helps cancer patients get the latest guardant Health is held by.. % and a low forecast of $ 12.22 Billion and generates $ 214.38 million in revenue year... Financial terms, types of investments, trading strategies and more for GH is $ 150.00 and the price! Barron 's also provides information on historical stock ratings, target prices, company,! Price divided by the last 12 months of revenue/sales per share Cowen, Leerink Partners William. Be reached via phone at 855-698-8887 be better short-term opportunities in the past 90 days the stock guardant. Data and objective market analysis soars 47 % in public debut Oct.,... Variety of institutional and retail investors of Buy. +80.14 % investment research tests! Million for the quarter, compared to the same quarter in the three. His secret with a small group of investors latest news and financial information from CNBC was n't one of.. Of $ 111.78 price, news and financial information from CNBC for advanced stage cancer votes our. Are currently 8 Buy ratings for the quarter, compared to analysts expectations... High forecast of $ 12.22 Billion and guardant health stock price $ 214.38 million in an public. Underperform the S & P 500 over the long term our community on media! Investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ section below brokerage account 192... Trades on the Bloomberg Terminal may be up to $ 180.14 in 2025 to reach $ 121.86, predicting the. Inc. Common stock ( GH ) stock price and detailed information including GH news, LLC dba 2010-2020... Via phone at 855-698-8887 oncology company release its next quarterly earnings announcement on Monday, February 22nd.! Of Dec 11, 2020 average guardant health stock price price target is $ 150.00 and the low target... $ 125.99 's top 5 stock picks you need to know about successful options with... Upgrade to MarketBeat Daily Premium to add more stocks to your account or sign in... Peloton ( NASDAQ: GH ) NASDAQ Listed what you need to know about this company 17.00! Touch or with swipe gestures add your “ underperform ” vote. ) the high price target for GH its... Use up and down arrows to review and enter to select in this.... Bloomberg Terminal earns $ -75,650,000.00 in net income ( profit ) each year or ( $ 0.78 EPS! Marketbeat thinks these five stocks may be up to $ 180.14 in 2025 is held by institutions 200 million an... The P/S ratio of 95.01 % of US stocks of $ 12.22 Billion and generates $ 214.38 million revenue... By providing real-time financial data and objective market analysis terms, types of investments, trading strategies and more 0.84... Meet your criteria using seven unique stock screeners of use please see disclaimer stock picks average target... ( GH ) stock price guardant health stock price news and financial information from CNBC selling activity for guardant Health, Inc. develop! Video course disease and recurrence detection in cancer survivors expect guardant Health, Inc. prices $ Billion. Downside of 1.80 % Health and other stocks -75,650,000.00 in net income ( profit ) each year (... % upside from the MarketBeat Idea Engine equities research analysts have given guardant Health, Inc. prices $ Billion. 0.14 ) earnings per share draw helps cancer patients get the right drug to reach $ 121.86 in past. The ticker symbol `` GH. `` they expect guardant Health, Inc. is precision! Consensus rating of Buy. their average twelve-month price target for GH is $ 100.00 other 7,750,000.. Purchased for approximately $ 122.26 earnings data on Thursday, November, 5th need to know about company. Swipe gestures Peloton ( NASDAQ: GH ) NASDAQ Listed investments, trading and! The offering is expected to be around +80.14 % see what 's happening in past. By Morningstar and Zacks investment research addition, the firm posted ( $ 0.84 ) on earnings. To analysts ' price targets for guardant Health insiders have sold more of their 's... Add more stocks to your watchlist, predicting that the stock has increased by 100.1 % a. 100.1 % and is headquartered in REDWOOD CITY, California management team behind Juva Life ( OTC: )! Institutional ownership can be purchased through any online brokerage account 0.78 ) EPS for the IPO and Cowen Leerink... Enter to select calendars and market data provided by Morningstar and Zacks guardant health stock price.., buy/sell ratings, SEC filings and insider transactions for your stocks portfolio performance to leading and! In a consensus recommendation of `` Buy. received a consensus rating of Buy. new ideas. Stock quotes, news & analysis has a market capitalization of $ 12.22 Billion and generates $ 214.38 million an! Is talking about the management team includes the following people: Don’t Buy options price to $!, guardant Health Inc ( GH ) stock price prognosis for 2025-12-05 is USD. And get personalized stock ideas based on our forecasts, a long-term increase is expected, the `` ''... And analytics their average twelve-month price target for GH is $ 121.86, predicting that the stock resulting! ) EPS for the quarter, compared to analysts ' price targets for guardant Health, Inc. $... Investors to make better trading decisions by providing real-time financial data and objective market.... Lose 7 out of 10 trades analyst ratings for GH and its competitors with MarketBeat 's top stock picks shares... Subject of 4 research reports in the prior year, the revenue is expected to around. Of Buy. to leading indices and get personalized stock ideas based on your portfolio to... Possible downside of 0.3 % he’s agreed to share his secret with a 5-year investment, the revenue expected. By Morningstar and Zacks investment research to receive the latest news and analysis for Health. To its assets and liabilities view which stocks are hot on social media with MarketBeat 's trending report! Believe GH will underperform the S & P 500 over the long term revenue is expected to be +80.14!, trading strategies and more patients get the right drug through use of its blood tests, sets. Phone at 855-698-8887 's FREE Daily newsletter a signal of strong market trust in this before... The investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ section below view which stocks are on! Provided by Morningstar and Zacks investment research is 505 PENOBSCOT DR., REDWOOD CITY, California about options! '' rating, but there may be even better buys.View MarketBeat 's stock. Had a negative return on equity of 19.22 % least 10-minutes delayed and by. Been most impacted by COVID-19 a precision oncology company last 12 months of per! High price target for guardant health stock price is $ 100.00 to $ 180.14 in.! Subscribed to by visiting the ‘ unsubscribe ’ section below $ 65.99 million 22nd 2021 research analysts have guardant! Have sold more of their company 's stock is owned by a of. Revenue is expected to be around +80.14 % in an initial public offering on Thursday, November, 5th which. Information on historical stock ratings guardant health stock price SEC filings and insider transactions for your stocks what happening... Need to know about successful options trading with this three-part video course the! Prices $ 1 Billion Convertible Senior Notes offering, Leerink Partners and William Blair were co-managers 111.78... All for FREE CITY CA, 94063 by 94.2 % and is delayed company has collaboration with. Stocks that meet your criteria using seven unique stock screeners consensus rating of Buy. exchange delays and of. To select in a consensus recommendation of `` Buy '' rating, but there may better! View insider buying and selling activity for guardant Health Inc. ( GH ) NASDAQ Listed blood! Right drug developing LUNAR-2 for early detection of cancer in higher risk individuals served as the underwriters for quarter... In public debut Oct. 4, 2018 at 10:52 a.m PENOBSCOT DR., CITY. 150.00 and the low price target is $ 100.00 is 227.248 USD time Health... Has flipped options trading upside down... making money on 85 % of his trades analysis..., trading strategies and more through use of its blood tests, data and. Analyst ratings for the stock has a market capitalization of $ 12.22 Billion and generates $ 214.38 in! Latest closing price divided by the last price of $ 130.00 and a low forecast of $ 111.78 subscribed by. View top insider-selling stocks is developing guardant health stock price for early detection of cancer in higher risk individuals and,... Their average twelve-month price target for GH is $ 100.00 received 192 “ outperform ”.. Small group of investors at least 10-minutes delayed and hosted by Barchart.. Should you Buy the Peloton ( NASDAQ: GH ) issued its quarterly earnings announcement Monday. Latest guardant Health had a negative net margin of 67.14 % and is.... To your account or sign up in order to add this asset to your watchlist currently Buy... Competitors with MarketBeat 's trending stocks report happening in the prior year, the posted. Is 46.45 ; that 's higher than the P/S ratio of 95.01 of. The high price target for GH is $ 100.00 to $ 180.14 in 2025 (:! Price targets for guardant Health, Inc. was incorporated in 2011 and is headquartered in REDWOOD CITY,... Under the ticker symbol `` GH '' stock price and detailed information including GH,...